| Dr Richard Werner Barth, MD | |
|
2021 K St Nw, Suite 400, Washington, DC 20006-1003 | |
| (202) 466-5151 | |
| (202) 466-4072 |
| Full Name | Dr Richard Werner Barth |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 2021 K St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124133384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 20896 (District Of Columbia) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 20896 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Orthopaedics And Sports Medicine, P.a. | 9739163668 | 33 |
News Archive
Common pain and fever Acetaminophen (best known by the brand name Tylenol) taken over a long time can cause liver failure and death, according to a new study.
College life can be rigorous and exhausting, but new research suggests that just one extra hour of sleep a night is not only possible, but can also have significant health benefits for college students.
Breast cancer patients face complex decisions about their treatment. "Knowledge is a key component of decision making, and yet it's consistently low even among patients who have received treatment. We need better tools to make these decisions more informed," says Sarah T. Hawley, Ph.D., MPH, professor of internal medicine at Michigan Medicine.
Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.
› Verified 3 days ago
| Entity Name | Washington Orthopaedics And Sports Medicine, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780628131 PECOS PAC ID: 9739163668 Enrollment ID: O20040617000053 |
News Archive
Common pain and fever Acetaminophen (best known by the brand name Tylenol) taken over a long time can cause liver failure and death, according to a new study.
College life can be rigorous and exhausting, but new research suggests that just one extra hour of sleep a night is not only possible, but can also have significant health benefits for college students.
Breast cancer patients face complex decisions about their treatment. "Knowledge is a key component of decision making, and yet it's consistently low even among patients who have received treatment. We need better tools to make these decisions more informed," says Sarah T. Hawley, Ph.D., MPH, professor of internal medicine at Michigan Medicine.
Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Werner Barth, MD 5454 Wisconsin Ave, Suite 1000, Chevy Chase, MD 20815-6901 Ph: (301) 657-1996 | Dr Richard Werner Barth, MD 2021 K St Nw, Suite 400, Washington, DC 20006-1003 Ph: (202) 466-5151 |
News Archive
Common pain and fever Acetaminophen (best known by the brand name Tylenol) taken over a long time can cause liver failure and death, according to a new study.
College life can be rigorous and exhausting, but new research suggests that just one extra hour of sleep a night is not only possible, but can also have significant health benefits for college students.
Breast cancer patients face complex decisions about their treatment. "Knowledge is a key component of decision making, and yet it's consistently low even among patients who have received treatment. We need better tools to make these decisions more informed," says Sarah T. Hawley, Ph.D., MPH, professor of internal medicine at Michigan Medicine.
Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.
› Verified 3 days ago
Fred Mo, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8766 Fax: 202-444-1655 | |
Dr. Panagiotis A Labropoulos, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2150 Pennsylvania Ave Nw, 7th Floor, Washington, DC 20037 Phone: 202-741-3305 Fax: 202-741-3313 | |
Dr. Harvey M. Cohen, M. D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: Walter Reed Army Medical Ctr, Washington, DC 20307 Phone: 202-782-0292 Fax: 202-782-6845 | |
Olivia Mae Larussa, PA-C Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-741-3000 | |
Dr. Craig Robert Faulks, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Washington Cir Nw, Suite 404, Washington, DC 20037 Phone: 202-333-2820 Fax: 202-833-1410 | |
Dr. Melinda Miller Gardner, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw, Ste 248, Washington, DC 20016 Phone: 202-244-0706 Fax: 202-686-6278 | |
Shannon Mcclure Kelly, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Orthopaedic Surgery, Washington, DC 20010 Phone: 202-476-4063 Fax: 202-476-4613 |